Genmab and Seagen’s cervical cancer drug Tivdak has reached its primary endpoint in a confirmatory Phase III trial, and the results are expected to support
Novavax is gearing up for fall vaccine season with a campaign that includes TikTok ads and a devil’s advocate. In a new 50-second TikTok video,
Illumina has picked Jacob Thaysen as its new CEO, roughly three months after the company parted ways with Francis deSouza following a fight with an activist
Beam Therapeutics announced Tuesday that it dosed its first patient with its base-edited CAR-T treatment last month. BEAM-201 is an “off-the-shelf” cell therapy for patients
An RNA editing therapy may be headed into human testing for the first time, after Wave Life Sciences submitted an application to bring the treatment
Adding regorafenib (Stivarga) to a standard first-line chemoimmunotherapy regimen for HER2-negative metastatic esophagogastric cancer demonstrated “promising” activity in a single-arm phase II study, according to
Most respondents to a survey conducted at an academic medical center were not informed of the relationship between human papillomavirus (HPV) and throat cancer by
Getting vaccinated wasn’t tied to an uptick in multiple sclerosis (MS) flare-ups in a large national study from France. Hospitalization for an MS flare showed
Following a trio of fatal cases in the Northeast, the CDC is alerting healthcare professionals to suspect Vibrio vulnificus infection, which requires rapid treatment to
Eye-tracking-based measurement of social visual engagement — how kids look at and learn from their social environment — was predictive of autism diagnosis by clinical